November 18, 2026
Health news, explained with evidence
LIVE

Discontinuing Statins After Age 70 May Carry Long-Term Risks, Study Finds

🔬 Research 2 min read 👁 5

New research suggests that while stopping statins at age 70 or older may not immediately raise cardiovascular risk, a longer-term follow-up points to an increased rate of heart attacks, strokes, and death.

Discontinuing Statins After Age 70 May Carry Long-Term Risks, Study Finds🔬Research

Photo: ScienceDaily Cancer

Key points

  • Study evaluated nearly 1,900 adults aged 70 and older with no prior heart attack or stroke.
  • Short-term safety over two years showed no significant increase in immediate cardiovascular events.
  • Longer follow-up up to four years linked stopping statins to a higher rate of serious health outcomes.

A preliminary study presented at the American Heart Association's Scientific Sessions 2026 in Chicago indicates that adults aged 70 and older who have never suffered a heart attack or stroke might safely pause statin use in the short term, though long-term risks remain. Statins are frequently prescribed to lower low-density lipoprotein-cholesterol, or "bad cholesterol," which builds up in arteries and contributes to cardiovascular events. Current guidelines recommend preventive treatments for elevated cholesterol, but questions persist regarding whether the benefits continue into later decades of life.

Led by Rita F. Redberg, a professor of cardiology at the University of California, San Francisco School of Medicine, the study evaluated nearly 1,900 adults aged 70 and older. All participants took statins for primary prevention and managed at least two chronic conditions, such as lung disease or cancer. Researchers randomized participants to either stop or continue their statin therapy, tracking health outcomes for roughly two years, with extended follow-up reaching up to four years.

During the initial two-year window, discontinuing statins did not trigger a statistically significant rise in heart attacks, strokes, or deaths compared to the group that kept taking the medications. Additionally, stopping treatment yielded no noticeable differences in muscle pain, quality of life, falls, or muscle wasting. However, the data did hint at a minor difference, showing roughly one extra cardiovascular event for every 40 individuals who stopped the medication over the two-year span.

A more concerning trend emerged during the extended follow-up of up to four years. Among participants who stopped statins, 12.7% experienced a heart attack, stroke, or death, compared to 9.2% of those who maintained their treatment. Researchers noted that this longer-term divergence underscores the complexity of halting cholesterol therapies later in life.

  • What to know: Adults over 70 taking statins for primary prevention may face higher long-term risks if they discontinue the medication, despite reassuring short-term data.
  • Always consult a healthcare professional before making any personal decisions regarding prescription medications or treatment plans.

Source ScienceDaily Cancer — sciencedaily.com/releases/2026/11/261112025534.htm ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.